Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

GORE Flow Reversal System and GORE Embolic Filter Extension Study
The Gore FREEDOM Study: GORE Flow Reversal System and GORE Embolic Filter Extension Study for the Ongoing Collection of Patient Outcomes
Status: Enrolling
Updated:  1/22/2016
Heritage Valley Health Network
mi
from
Beaver, PA
GORE Flow Reversal System and GORE Embolic Filter Extension Study
The Gore FREEDOM Study: GORE Flow Reversal System and GORE Embolic Filter Extension Study for the Ongoing Collection of Patient Outcomes
Status: Enrolling
Updated: 1/22/2016
Heritage Valley Health Network
mi
from
Beaver, PA
Click here to add this to my saved trials
GORE Flow Reversal System and GORE Embolic Filter Extension Study
The Gore FREEDOM Study: GORE Flow Reversal System and GORE Embolic Filter Extension Study for the Ongoing Collection of Patient Outcomes
Status: Enrolling
Updated:  1/22/2016
Spirit Physician Services / Capital Cardiovascular Assoc
mi
from
Camp Hill, PA
GORE Flow Reversal System and GORE Embolic Filter Extension Study
The Gore FREEDOM Study: GORE Flow Reversal System and GORE Embolic Filter Extension Study for the Ongoing Collection of Patient Outcomes
Status: Enrolling
Updated: 1/22/2016
Spirit Physician Services / Capital Cardiovascular Assoc
mi
from
Camp Hill, PA
Click here to add this to my saved trials
GORE Flow Reversal System and GORE Embolic Filter Extension Study
The Gore FREEDOM Study: GORE Flow Reversal System and GORE Embolic Filter Extension Study for the Ongoing Collection of Patient Outcomes
Status: Enrolling
Updated:  1/22/2016
Drexel University
mi
from
Philadelphia, PA
GORE Flow Reversal System and GORE Embolic Filter Extension Study
The Gore FREEDOM Study: GORE Flow Reversal System and GORE Embolic Filter Extension Study for the Ongoing Collection of Patient Outcomes
Status: Enrolling
Updated: 1/22/2016
Drexel University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
GORE Flow Reversal System and GORE Embolic Filter Extension Study
The Gore FREEDOM Study: GORE Flow Reversal System and GORE Embolic Filter Extension Study for the Ongoing Collection of Patient Outcomes
Status: Enrolling
Updated:  1/22/2016
York Hospital
mi
from
York, PA
GORE Flow Reversal System and GORE Embolic Filter Extension Study
The Gore FREEDOM Study: GORE Flow Reversal System and GORE Embolic Filter Extension Study for the Ongoing Collection of Patient Outcomes
Status: Enrolling
Updated: 1/22/2016
York Hospital
mi
from
York, PA
Click here to add this to my saved trials
GORE Flow Reversal System and GORE Embolic Filter Extension Study
The Gore FREEDOM Study: GORE Flow Reversal System and GORE Embolic Filter Extension Study for the Ongoing Collection of Patient Outcomes
Status: Enrolling
Updated:  1/22/2016
Medical University of South Carolina
mi
from
Charleston, SC
GORE Flow Reversal System and GORE Embolic Filter Extension Study
The Gore FREEDOM Study: GORE Flow Reversal System and GORE Embolic Filter Extension Study for the Ongoing Collection of Patient Outcomes
Status: Enrolling
Updated: 1/22/2016
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
GORE Flow Reversal System and GORE Embolic Filter Extension Study
The Gore FREEDOM Study: GORE Flow Reversal System and GORE Embolic Filter Extension Study for the Ongoing Collection of Patient Outcomes
Status: Enrolling
Updated:  1/22/2016
Rapid City Regional Hospital
mi
from
Rapid City, SD
GORE Flow Reversal System and GORE Embolic Filter Extension Study
The Gore FREEDOM Study: GORE Flow Reversal System and GORE Embolic Filter Extension Study for the Ongoing Collection of Patient Outcomes
Status: Enrolling
Updated: 1/22/2016
Rapid City Regional Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
GORE Flow Reversal System and GORE Embolic Filter Extension Study
The Gore FREEDOM Study: GORE Flow Reversal System and GORE Embolic Filter Extension Study for the Ongoing Collection of Patient Outcomes
Status: Enrolling
Updated:  1/22/2016
N. Central Heart Hospital
mi
from
Sioux Falls, SD
GORE Flow Reversal System and GORE Embolic Filter Extension Study
The Gore FREEDOM Study: GORE Flow Reversal System and GORE Embolic Filter Extension Study for the Ongoing Collection of Patient Outcomes
Status: Enrolling
Updated: 1/22/2016
N. Central Heart Hospital
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
GORE Flow Reversal System and GORE Embolic Filter Extension Study
The Gore FREEDOM Study: GORE Flow Reversal System and GORE Embolic Filter Extension Study for the Ongoing Collection of Patient Outcomes
Status: Enrolling
Updated:  1/22/2016
St. Luke's Episcopal
mi
from
Houston, TX
GORE Flow Reversal System and GORE Embolic Filter Extension Study
The Gore FREEDOM Study: GORE Flow Reversal System and GORE Embolic Filter Extension Study for the Ongoing Collection of Patient Outcomes
Status: Enrolling
Updated: 1/22/2016
St. Luke's Episcopal
mi
from
Houston, TX
Click here to add this to my saved trials
GORE Flow Reversal System and GORE Embolic Filter Extension Study
The Gore FREEDOM Study: GORE Flow Reversal System and GORE Embolic Filter Extension Study for the Ongoing Collection of Patient Outcomes
Status: Enrolling
Updated:  1/22/2016
Appleton Medical Cetner
mi
from
Appleton, WI
GORE Flow Reversal System and GORE Embolic Filter Extension Study
The Gore FREEDOM Study: GORE Flow Reversal System and GORE Embolic Filter Extension Study for the Ongoing Collection of Patient Outcomes
Status: Enrolling
Updated: 1/22/2016
Appleton Medical Cetner
mi
from
Appleton, WI
Click here to add this to my saved trials
GORE Flow Reversal System and GORE Embolic Filter Extension Study
The Gore FREEDOM Study: GORE Flow Reversal System and GORE Embolic Filter Extension Study for the Ongoing Collection of Patient Outcomes
Status: Enrolling
Updated:  1/22/2016
University of Wisconsin
mi
from
Madison, WI
GORE Flow Reversal System and GORE Embolic Filter Extension Study
The Gore FREEDOM Study: GORE Flow Reversal System and GORE Embolic Filter Extension Study for the Ongoing Collection of Patient Outcomes
Status: Enrolling
Updated: 1/22/2016
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
GORE Flow Reversal System and GORE Embolic Filter Extension Study
The Gore FREEDOM Study: GORE Flow Reversal System and GORE Embolic Filter Extension Study for the Ongoing Collection of Patient Outcomes
Status: Enrolling
Updated:  1/22/2016
St. Luke's Medical Center
mi
from
Milwaukee, WI
GORE Flow Reversal System and GORE Embolic Filter Extension Study
The Gore FREEDOM Study: GORE Flow Reversal System and GORE Embolic Filter Extension Study for the Ongoing Collection of Patient Outcomes
Status: Enrolling
Updated: 1/22/2016
St. Luke's Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
An Exploration of the Relationship Between Chronic Pain and Suicide Attempt Among Veterans
An Exploration of the Relationship Between Chronic Pain and Suicide Attempt Among Veterans
Status: Enrolling
Updated:  1/22/2016
Eastern Colorado Healthcare System
mi
from
Denver, CO
An Exploration of the Relationship Between Chronic Pain and Suicide Attempt Among Veterans
An Exploration of the Relationship Between Chronic Pain and Suicide Attempt Among Veterans
Status: Enrolling
Updated: 1/22/2016
Eastern Colorado Healthcare System
mi
from
Denver, CO
Click here to add this to my saved trials
Imaging Biomarkers of Delayed Sequelae in Trauma Brain Injury
Imaging Biomarkers of Delayed Sequelae in Mild to Moderate Traumatic Brain Injury
Status: Enrolling
Updated:  1/22/2016
NorthShore University HealthSystem
mi
from
Evanston, IL
Imaging Biomarkers of Delayed Sequelae in Trauma Brain Injury
Imaging Biomarkers of Delayed Sequelae in Mild to Moderate Traumatic Brain Injury
Status: Enrolling
Updated: 1/22/2016
NorthShore University HealthSystem
mi
from
Evanston, IL
Click here to add this to my saved trials
Why Are Patients With Absence Seizures Absent? A Brain Imaging Study
Functional Neuroimaging in Childhood Absence Epilepsy
Status: Enrolling
Updated:  1/25/2016
Yale University School of Medicine, Neurology Department
mi
from
New Haven, CT
Why Are Patients With Absence Seizures Absent? A Brain Imaging Study
Functional Neuroimaging in Childhood Absence Epilepsy
Status: Enrolling
Updated: 1/25/2016
Yale University School of Medicine, Neurology Department
mi
from
New Haven, CT
Click here to add this to my saved trials
Evaluation of an School-based Alcohol Prevention Program for Middle School Students
Evaluation of an Intranet-Based Alcohol Prevention Program in Middle School
Status: Enrolling
Updated:  1/25/2016
Oregon Research Institute
mi
from
Eugene, OR
Evaluation of an School-based Alcohol Prevention Program for Middle School Students
Evaluation of an Intranet-Based Alcohol Prevention Program in Middle School
Status: Enrolling
Updated: 1/25/2016
Oregon Research Institute
mi
from
Eugene, OR
Click here to add this to my saved trials
Reliability of an Algorithm to Diagnose Spasticity
Inter-Rater Reliability of a Spasticity Diagnosis Algorithm
Status: Enrolling
Updated:  1/25/2016
Tennessee State Veterans Home
mi
from
Murfreesboro, TN
Reliability of an Algorithm to Diagnose Spasticity
Inter-Rater Reliability of a Spasticity Diagnosis Algorithm
Status: Enrolling
Updated: 1/25/2016
Tennessee State Veterans Home
mi
from
Murfreesboro, TN
Click here to add this to my saved trials
Reliability of an Algorithm to Diagnose Spasticity
Inter-Rater Reliability of a Spasticity Diagnosis Algorithm
Status: Enrolling
Updated:  1/25/2016
Trevecca Health & Rehab
mi
from
Nashville, TN
Reliability of an Algorithm to Diagnose Spasticity
Inter-Rater Reliability of a Spasticity Diagnosis Algorithm
Status: Enrolling
Updated: 1/25/2016
Trevecca Health & Rehab
mi
from
Nashville, TN
Click here to add this to my saved trials
Reliability of an Algorithm to Diagnose Spasticity
Inter-Rater Reliability of a Spasticity Diagnosis Algorithm
Status: Enrolling
Updated:  1/25/2016
Bethany Health & Rehabilitation Center
mi
from
Nashville, TN
Reliability of an Algorithm to Diagnose Spasticity
Inter-Rater Reliability of a Spasticity Diagnosis Algorithm
Status: Enrolling
Updated: 1/25/2016
Bethany Health & Rehabilitation Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Prevalence of Spasticity in Veterans Living in a Long-term Care Facility
Prevalence of Spasticity in Veterans Living in a Long-term Care Facility
Status: Enrolling
Updated:  1/25/2016
Tennessee State Veterans Home
mi
from
Murfreesboro, TN
Prevalence of Spasticity in Veterans Living in a Long-term Care Facility
Prevalence of Spasticity in Veterans Living in a Long-term Care Facility
Status: Enrolling
Updated: 1/25/2016
Tennessee State Veterans Home
mi
from
Murfreesboro, TN
Click here to add this to my saved trials
Effectiveness Study of Videoconferencing on Teaching Parent Training Skills to Parents of Children With Attention Deficit Hyperactivity Disorder (ADHD)
The Effectiveness of Videoconferencing on Teaching Parent Training Skills to Parents of Children With ADHD
Status: Enrolling
Updated:  1/25/2016
UC Davis MIND Institute
mi
from
Sacramento, CA
Effectiveness Study of Videoconferencing on Teaching Parent Training Skills to Parents of Children With Attention Deficit Hyperactivity Disorder (ADHD)
The Effectiveness of Videoconferencing on Teaching Parent Training Skills to Parents of Children With ADHD
Status: Enrolling
Updated: 1/25/2016
UC Davis MIND Institute
mi
from
Sacramento, CA
Click here to add this to my saved trials
MRI and Neurodevelopment in Preterm Infants Following Administration of High-Dose Caffeine
Magnetic Resonance Imaging and Neurodevelopmental Outcomes in Preterm Infants Following Administration of High-Dose Caffeine - A Pilot Study
Status: Enrolling
Updated:  1/26/2016
St. Louis Children's Hospital
mi
from
St. Louis, MO
MRI and Neurodevelopment in Preterm Infants Following Administration of High-Dose Caffeine
Magnetic Resonance Imaging and Neurodevelopmental Outcomes in Preterm Infants Following Administration of High-Dose Caffeine - A Pilot Study
Status: Enrolling
Updated: 1/26/2016
St. Louis Children's Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
Organ Donor Tissue Oxygen Saturation as a Predictor of Number of Organs to Transplant Per Donor
Tissue Oxygen Saturation During Management of the Deceased by Neurological Criteria Organ Donor as a Predictor of Number of Organs to Transplant Per Donor
Status: Enrolling
Updated:  1/26/2016
Cleveland Clinic
mi
from
Cleveland, OH
Organ Donor Tissue Oxygen Saturation as a Predictor of Number of Organs to Transplant Per Donor
Tissue Oxygen Saturation During Management of the Deceased by Neurological Criteria Organ Donor as a Predictor of Number of Organs to Transplant Per Donor
Status: Enrolling
Updated: 1/26/2016
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Predictive Executive Functioning Models Using Interactive Tangible-Graphical Interface Devices in Adults
Predictive Executive Functioning Models Using Interactive Tangible-Graphical Interface Devices in Adults
Status: Enrolling
Updated:  1/26/2016
Macalester College
mi
from
St. Paul, MN
Predictive Executive Functioning Models Using Interactive Tangible-Graphical Interface Devices in Adults
Predictive Executive Functioning Models Using Interactive Tangible-Graphical Interface Devices in Adults
Status: Enrolling
Updated: 1/26/2016
Macalester College
mi
from
St. Paul, MN
Click here to add this to my saved trials
Vestibular Rehabilitation Strategies in PTSD Effectiveness of Carrick Brain Centers Strategies Vestibular Rehabilitation Treatment in PTSD Patients Who Have Suffered Combat Related Traumatic Brain Injuries
A Randomized Controlled Trial Comparison of the Effectiveness of Carrick Brain Centers Strategies Vestibular Rehabilitation Treatment in PTSD Patients Who Have Suffered Combat Related Traumatic Brain Injuries.
Status: Enrolling
Updated:  1/26/2016
Carrick Brain Centers
mi
from
Irving, TX
Vestibular Rehabilitation Strategies in PTSD Effectiveness of Carrick Brain Centers Strategies Vestibular Rehabilitation Treatment in PTSD Patients Who Have Suffered Combat Related Traumatic Brain Injuries
A Randomized Controlled Trial Comparison of the Effectiveness of Carrick Brain Centers Strategies Vestibular Rehabilitation Treatment in PTSD Patients Who Have Suffered Combat Related Traumatic Brain Injuries.
Status: Enrolling
Updated: 1/26/2016
Carrick Brain Centers
mi
from
Irving, TX
Click here to add this to my saved trials
Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
A Randomized, Double-blind, Placebo-controlled Study of RAD0001 in the Treatment of Angiomyolipoma in Patients With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
Status: Enrolling
Updated:  1/26/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
A Randomized, Double-blind, Placebo-controlled Study of RAD0001 in the Treatment of Angiomyolipoma in Patients With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
Status: Enrolling
Updated: 1/26/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
A Randomized, Double-blind, Placebo-controlled Study of RAD0001 in the Treatment of Angiomyolipoma in Patients With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
Status: Enrolling
Updated:  1/26/2016
Barrow Tuberous Sclerosis Center
mi
from
Phoenix, AZ
Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
A Randomized, Double-blind, Placebo-controlled Study of RAD0001 in the Treatment of Angiomyolipoma in Patients With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
Status: Enrolling
Updated: 1/26/2016
Barrow Tuberous Sclerosis Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
A Randomized, Double-blind, Placebo-controlled Study of RAD0001 in the Treatment of Angiomyolipoma in Patients With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
Status: Enrolling
Updated:  1/26/2016
Massachusetts General Hospital Massachussetts General Hospita
mi
from
Boston, MA
Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
A Randomized, Double-blind, Placebo-controlled Study of RAD0001 in the Treatment of Angiomyolipoma in Patients With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
Status: Enrolling
Updated: 1/26/2016
Massachusetts General Hospital Massachussetts General Hospita
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
A Randomized, Double-blind, Placebo-controlled Study of RAD0001 in the Treatment of Angiomyolipoma in Patients With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
Status: Enrolling
Updated:  1/26/2016
Minnesota Epilepsy Group, P.A.
mi
from
St. Paul, MN
Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
A Randomized, Double-blind, Placebo-controlled Study of RAD0001 in the Treatment of Angiomyolipoma in Patients With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
Status: Enrolling
Updated: 1/26/2016
Minnesota Epilepsy Group, P.A.
mi
from
St. Paul, MN
Click here to add this to my saved trials
Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
A Randomized, Double-blind, Placebo-controlled Study of RAD0001 in the Treatment of Angiomyolipoma in Patients With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
Status: Enrolling
Updated:  1/26/2016
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
A Randomized, Double-blind, Placebo-controlled Study of RAD0001 in the Treatment of Angiomyolipoma in Patients With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
Status: Enrolling
Updated: 1/26/2016
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
A Randomized, Double-blind, Placebo-controlled Study of RAD0001 in the Treatment of Angiomyolipoma in Patients With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
Status: Enrolling
Updated:  1/26/2016
LeBonheur Childrens Medical Group SC-2
mi
from
Memphis, TN
Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
A Randomized, Double-blind, Placebo-controlled Study of RAD0001 in the Treatment of Angiomyolipoma in Patients With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
Status: Enrolling
Updated: 1/26/2016
LeBonheur Childrens Medical Group SC-2
mi
from
Memphis, TN
Click here to add this to my saved trials
Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
A Randomized, Double-blind, Placebo-controlled Study of RAD0001 in the Treatment of Angiomyolipoma in Patients With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
Status: Enrolling
Updated:  1/26/2016
Novartis Investigative Site
mi
from
Torono,
Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
A Randomized, Double-blind, Placebo-controlled Study of RAD0001 in the Treatment of Angiomyolipoma in Patients With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
Status: Enrolling
Updated: 1/26/2016
Novartis Investigative Site
mi
from
Torono,
Click here to add this to my saved trials
Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple Sclerosis
Long-term Extension of the Multinational, Double-blind, Placebo Controlled Study EFC6049 (HMR1726D/3001) to Document the Safety of Two Doses of Teriflunomide (7 and 14 mg) in Patients With Multiple Sclerosis With Relapses
Status: Enrolling
Updated:  1/26/2016
Clinical Research Facility
mi
from
Maitland, FL
Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple Sclerosis
Long-term Extension of the Multinational, Double-blind, Placebo Controlled Study EFC6049 (HMR1726D/3001) to Document the Safety of Two Doses of Teriflunomide (7 and 14 mg) in Patients With Multiple Sclerosis With Relapses
Status: Enrolling
Updated: 1/26/2016
Clinical Research Facility
mi
from
Maitland, FL
Click here to add this to my saved trials
Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple Sclerosis
Long-term Extension of the Multinational, Double-blind, Placebo Controlled Study EFC6049 (HMR1726D/3001) to Document the Safety of Two Doses of Teriflunomide (7 and 14 mg) in Patients With Multiple Sclerosis With Relapses
Status: Enrolling
Updated:  1/26/2016
Clinical Research Facility
mi
from
Ft. Wayne, IN
Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple Sclerosis
Long-term Extension of the Multinational, Double-blind, Placebo Controlled Study EFC6049 (HMR1726D/3001) to Document the Safety of Two Doses of Teriflunomide (7 and 14 mg) in Patients With Multiple Sclerosis With Relapses
Status: Enrolling
Updated: 1/26/2016
Clinical Research Facility
mi
from
Ft. Wayne, IN
Click here to add this to my saved trials
Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple Sclerosis
Long-term Extension of the Multinational, Double-blind, Placebo Controlled Study EFC6049 (HMR1726D/3001) to Document the Safety of Two Doses of Teriflunomide (7 and 14 mg) in Patients With Multiple Sclerosis With Relapses
Status: Enrolling
Updated:  1/26/2016
Clinical Research Facility
mi
from
Detroit, MI
Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple Sclerosis
Long-term Extension of the Multinational, Double-blind, Placebo Controlled Study EFC6049 (HMR1726D/3001) to Document the Safety of Two Doses of Teriflunomide (7 and 14 mg) in Patients With Multiple Sclerosis With Relapses
Status: Enrolling
Updated: 1/26/2016
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple Sclerosis
Long-term Extension of the Multinational, Double-blind, Placebo Controlled Study EFC6049 (HMR1726D/3001) to Document the Safety of Two Doses of Teriflunomide (7 and 14 mg) in Patients With Multiple Sclerosis With Relapses
Status: Enrolling
Updated:  1/26/2016
Clinical Research Facility
mi
from
Allentown, PA
Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple Sclerosis
Long-term Extension of the Multinational, Double-blind, Placebo Controlled Study EFC6049 (HMR1726D/3001) to Document the Safety of Two Doses of Teriflunomide (7 and 14 mg) in Patients With Multiple Sclerosis With Relapses
Status: Enrolling
Updated: 1/26/2016
Clinical Research Facility
mi
from
Allentown, PA
Click here to add this to my saved trials
Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple Sclerosis
Long-term Extension of the Multinational, Double-blind, Placebo Controlled Study EFC6049 (HMR1726D/3001) to Document the Safety of Two Doses of Teriflunomide (7 and 14 mg) in Patients With Multiple Sclerosis With Relapses
Status: Enrolling
Updated:  1/26/2016
509
mi
from
Graz,
Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple Sclerosis
Long-term Extension of the Multinational, Double-blind, Placebo Controlled Study EFC6049 (HMR1726D/3001) to Document the Safety of Two Doses of Teriflunomide (7 and 14 mg) in Patients With Multiple Sclerosis With Relapses
Status: Enrolling
Updated: 1/26/2016
509
mi
from
Graz,
Click here to add this to my saved trials
A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients
A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients.
Status: Enrolling
Updated:  1/27/2016
University of New Mexico Cancer Center
mi
from
Albuquerque, NM
A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients
A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients.
Status: Enrolling
Updated: 1/27/2016
University of New Mexico Cancer Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients
A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients.
Status: Enrolling
Updated:  1/27/2016
Hematology Oncology Associates, PC
mi
from
Albuquerque, NM
A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients
A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients.
Status: Enrolling
Updated: 1/27/2016
Hematology Oncology Associates, PC
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients
A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients.
Status: Enrolling
Updated:  1/27/2016
University of New Mexico Cancer Center @ Lovelace Medical Center
mi
from
Albuquerque, NM
A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients
A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients.
Status: Enrolling
Updated: 1/27/2016
University of New Mexico Cancer Center @ Lovelace Medical Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients
A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients.
Status: Enrolling
Updated:  1/27/2016
Cancer Center at Presbyterian Hospital
mi
from
Albuquerque, NM
A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients
A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients.
Status: Enrolling
Updated: 1/27/2016
Cancer Center at Presbyterian Hospital
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients
A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients.
Status: Enrolling
Updated:  1/27/2016
New Mexico Cancer Care Associates
mi
from
Santa Fe, NM
A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients
A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients.
Status: Enrolling
Updated: 1/27/2016
New Mexico Cancer Care Associates
mi
from
Santa Fe, NM
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Harmonex Neuroscience Research
mi
from
Dothan, AL
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Harmonex Neuroscience Research
mi
from
Dothan, AL
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Southwest Autism Research and Resource Center
mi
from
Phoenix, AZ
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Southwest Autism Research and Resource Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Newport Beach Clinical Research Associates, Inc.
mi
from
Newport Beach, CA
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Newport Beach Clinical Research Associates, Inc.
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Florida Clinical Research Center, LLC
mi
from
Bradenton, FL
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Florida Clinical Research Center, LLC
mi
from
Bradenton, FL
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Sarkis Clinical Trials - Parent
mi
from
Gainesville, FL
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Sarkis Clinical Trials - Parent
mi
from
Gainesville, FL
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Palm Springs Research Institute
mi
from
Hialeah, FL
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Palm Springs Research Institute
mi
from
Hialeah, FL
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Florida Clinical Research Center LLC
mi
from
Maitland, FL
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Florida Clinical Research Center LLC
mi
from
Maitland, FL
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
University of South Florida
mi
from
Saint Petersburg, FL
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
University of South Florida
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials